Christopher O’Donnell, Ph.D.

Christopher O’Donnell, Ph.D.

Christopher O’Donnell, Ph.D. is a Partner at Pfizer Ventures and Vice President, Worldwide Business Development. Chris is responsible for identifying, evaluating, making, and managing equity investments aligned with the future directions of Pfizer. He currently has...
Troy Wilson, Ph.D., J.D.

Troy Wilson, Ph.D., J.D.

Troy Wilson is a serial entrepreneur whose passion lies in building exceptional biotech companies to advance patient care. As co-founder, President, Chief Executive Officer, and Chairman of the Board of Kura Oncology (NASDAQ: KURA) since its inception, Dr. Wilson and...
Kevin Parker, Ph.D.

Kevin Parker, Ph.D.

Kevin Parker is the CEO and co-founder of Cartography Biosciences.  Kevin completed his PhD at Stanford working in the interface of genomics, immunology, and computational biology.  He holds a B.A. in Human Developmental and Regenerative Biology from Harvard...
Becky Pfenderhirt

Becky Pfenderhirt

Becky Pferdehirt is an investing partner on the a16z Bio + Health team. Prior to joining Andreessen Horowitz, Becky worked at Amgen where she most recently led business development efforts for therapeutic platform partnerships. Before moving to BD Becky was a research...